Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease

Familial dysalbuminemic hyperthyroxinemia (FDH) is a cause of discordant thyroid function tests (TFTs), due to interference in free T4 assays, caused by the mutant albumin. The coexistence of thyroid disease and FDH can further complicate diagnosis and potentially result in inappropriate management....

Full description

Bibliographic Details
Main Authors: Serena Khoo, Greta Lyons, Andrew Solomon, Susan Oddy, David Halsall, Krishna Chatterjee, Carla Moran
Format: Article
Language:English
Published: Bioscientifica 2020-02-01
Series:Endocrinology, Diabetes & Metabolism Case Reports
id doaj-3f85248b483c46b69e1dfeb0a02b6bab
record_format Article
spelling doaj-3f85248b483c46b69e1dfeb0a02b6bab2020-11-25T03:09:21ZengBioscientificaEndocrinology, Diabetes & Metabolism Case Reports2052-05732052-05732020-02-01111510.1530/EDM-19-0161Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid diseaseSerena Khoo0Greta Lyons1Andrew Solomon2Susan Oddy3David Halsall4Krishna Chatterjee5Carla Moran6Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UKWellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UKDepartment of Medicine and Endocrinology, Lister Hospital, Stevenage, UKDepartment of Clinical Biochemistry, Addenbrooke’s Hospital, Cambridge, UKDepartment of Clinical Biochemistry, Addenbrooke’s Hospital, Cambridge, UKWellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UKWellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UKFamilial dysalbuminemic hyperthyroxinemia (FDH) is a cause of discordant thyroid function tests (TFTs), due to interference in free T4 assays, caused by the mutant albumin. The coexistence of thyroid disease and FDH can further complicate diagnosis and potentially result in inappropriate management. We describe a case of both Hashimoto’s thyroiditis and Graves’ disease occurring on a background of FDH. A 42-year-old lady with longstanding autoimmune hypothyroidism was treated with thyroxine but in varying dosage, because TFTs, showing high Free T4 (FT4) and normal TSH levels, were discordant. Discontinuation of thyroxine led to marked TSH rise but with normal FT4 levels. She then developed Graves’ disease and thyroid ophthalmopathy, with markedly elevated FT4 (62.7 pmol/L), suppressed TSH (<0.03 mU/L) and positive anti-TSH receptor antibody levels. However, propylthiouracil treatment even in low dosage (100 mg daily) resulted in profound hypothyroidism (TSH: 138 mU/L; FT4: 4.8 pmol/L), prompting its discontinuation and recommencement of thyroxine. The presence of discordant thyroid hormone measurements from two different methods suggested analytical interference. Elevated circulating total T4 (TT4), (227 nmol/L; NR: 69–141) but normal thyroxine binding globulin (TBG) (19.2 μg/mL; NR: 14.0–31.0) levels, together with increased binding of patient’s serum to radiolabelled T4, suggested FDH, and ALB sequencing confirmed a causal albumin variant (R218H). This case highlights difficulty ascertaining true thyroid status in patients with autoimmune thyroid disease and coexisting FDH. Early recognition of FDH as a cause for discordant TFTs may improve patient management.
collection DOAJ
language English
format Article
sources DOAJ
author Serena Khoo
Greta Lyons
Andrew Solomon
Susan Oddy
David Halsall
Krishna Chatterjee
Carla Moran
spellingShingle Serena Khoo
Greta Lyons
Andrew Solomon
Susan Oddy
David Halsall
Krishna Chatterjee
Carla Moran
Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
Endocrinology, Diabetes & Metabolism Case Reports
author_facet Serena Khoo
Greta Lyons
Andrew Solomon
Susan Oddy
David Halsall
Krishna Chatterjee
Carla Moran
author_sort Serena Khoo
title Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
title_short Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
title_full Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
title_fullStr Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
title_full_unstemmed Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
title_sort familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease
publisher Bioscientifica
series Endocrinology, Diabetes & Metabolism Case Reports
issn 2052-0573
2052-0573
publishDate 2020-02-01
description Familial dysalbuminemic hyperthyroxinemia (FDH) is a cause of discordant thyroid function tests (TFTs), due to interference in free T4 assays, caused by the mutant albumin. The coexistence of thyroid disease and FDH can further complicate diagnosis and potentially result in inappropriate management. We describe a case of both Hashimoto’s thyroiditis and Graves’ disease occurring on a background of FDH. A 42-year-old lady with longstanding autoimmune hypothyroidism was treated with thyroxine but in varying dosage, because TFTs, showing high Free T4 (FT4) and normal TSH levels, were discordant. Discontinuation of thyroxine led to marked TSH rise but with normal FT4 levels. She then developed Graves’ disease and thyroid ophthalmopathy, with markedly elevated FT4 (62.7 pmol/L), suppressed TSH (<0.03 mU/L) and positive anti-TSH receptor antibody levels. However, propylthiouracil treatment even in low dosage (100 mg daily) resulted in profound hypothyroidism (TSH: 138 mU/L; FT4: 4.8 pmol/L), prompting its discontinuation and recommencement of thyroxine. The presence of discordant thyroid hormone measurements from two different methods suggested analytical interference. Elevated circulating total T4 (TT4), (227 nmol/L; NR: 69–141) but normal thyroxine binding globulin (TBG) (19.2 μg/mL; NR: 14.0–31.0) levels, together with increased binding of patient’s serum to radiolabelled T4, suggested FDH, and ALB sequencing confirmed a causal albumin variant (R218H). This case highlights difficulty ascertaining true thyroid status in patients with autoimmune thyroid disease and coexisting FDH. Early recognition of FDH as a cause for discordant TFTs may improve patient management.
work_keys_str_mv AT serenakhoo familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT gretalyons familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT andrewsolomon familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT susanoddy familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT davidhalsall familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT krishnachatterjee familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
AT carlamoran familialdysalbuminemichyperthyroxinemiaconfoundingmanagementofcoexistentautoimmunethyroiddisease
_version_ 1724663190836477952